AGRX Agile Therapeutics, Inc.

2.96
+0  (10%)
Previous Close 2.69
Open 2.70
Price To book 1.83
Market Cap 85.18M
Shares 28,776,000
Volume 454,171
Short Ratio 6.49
Av. Daily Volume 713,438

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

CRL issued 2013. Phase 3 top-line data released January 3, 2017 - poor data but intends to reflile NDA 1H 2017.
Twirla
Contraceptive patch

Latest News

  1. AGILE THERAPEUTICS INC Financials
  2. Agile Therapeutics (AGRX) Catches Eye: Stock Moves Up 14%
  3. AGILE THERAPEUTICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
  4. AGILE THERAPEUTICS INC Files SEC form 10-K, Annual Report
  5. Agile Therapeutics reports 4Q loss
  6. Agile Therapeutics reports 4Q loss
  7. AGILE THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Ex
  8. Agile Therapeutics Reports Fourth Quarter and Full Year 2016 Financial Results
  9. IMPORTANT EQUITY ALERT: Khang & Khang LLP Announces a Class Action Lawsuit against Agile Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm
  10. DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Agile Therapeutics, Inc. (AGRX) & Lead Plaintiff Deadline - March 7, 2017
  11. SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Agile Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline – AGRX
  12. UPCOMING DEADLINE: Levi & Korsinsky, LLP Reminds Shareholders of Agile Therapeutics, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 7, 2017
  13. EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Agile Therapeutics, Inc. - AGRX
  14. Agile Therapeutics to Present at 29th Annual ROTH Conference
  15. DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Agile Therapeutics, Inc. (AGRX) and Lead Plaintiff Deadline - March 7, 2017
  16. IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces a Class Action Lawsuit against Agile Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm
  17. DEADLINE ALERT: Brower Piven Reminds Investors Of The March 7, 2017 Deadline In Class Action Lawsuit And Encourages Investors With Losses In Excess of $100,000 From Investment In Agile Therapeutics, Inc. To Contact The Firm
  18. INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Agile Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm
  19. AGRX INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Agile Therapeutics, Inc. and a Lead Plaintiff Deadline of March 7, 2017
  20. SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $50,000 Investing in Agile Therapeutics, Inc. to Contact the Firm Before Imminent Lead Plaintiff Deadline